Kunal Mahajan: Lipoprotein(a) and LDL-C Target Attainment in ACS Patients
Kunal Mahajan, Director and Chief Interventional Cardiologist at Himachal Heart Institute, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Happy to share our study in the Journal of Clinical Lipidology.
In ACS patients treated with triple oral lipid-lowering therapy, lipoprotein(a) increased significantly after ACS, and higher baseline lipoprotein(a) predicted failure to achieve low-density lipoprotein cholesterol less than fifty milligrams per deciliter at one month.”
Title: Changes in Lipoprotein(a) and Their Association With LDL-C in ACS Patients Treated with Triple Oral Lipid-Lowering Therapy
Authors: Kunal Mahajan, Nitin Mahajan, Jai Bharat Sharma, Surender Himral, Tanuj Bhatia, Deep Dutta
Read the Full Article on Journal of Clinical Lipidology
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 15:33Peter Zdziarski: Will Glanzmann Thrombasthenia Patients Be Formally Recognized as Benefiting from SevenFACT?
-
Apr 15, 2026, 15:20Sonal Sonu: Blood Donation Myths in Rural Areas
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
-
Apr 15, 2026, 14:39Pooja Choradia: Recognizing Pulmonary Embolism in Pregnancy Before It Is Too Late
-
Apr 15, 2026, 14:38Alessandra Bosch։ Understanding Haemostasis in Children and Its Challenges